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Maturation and secretion of rat hepatic lipase is inhibited by a1B-adrenergic
stimulation through changes in Ca2+ homoeostasis : thapsigargin and EGTA
both mimic the effect of adrenaline
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Department of Biochemistry, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands
In rats, the daily changes in hepatic lipase (HL) activity in the
liver follow the diurnal rhythm of the catecholamines. To study
the underlying mechanism, the effect of adrenaline on maturation
and secretion of HL was determined in freshly isolated rat
hepatocytes. Adrenaline (10 lM) acutely inhibited the secretion
of HL. This effect was abolished by 0±1 lM prazosin, but not by
1 lM propranolol, indicating the involvement of the a
"
-adren-
ergic pathway. Prazosin was at least 1000-fold more potent than
WB4101, a selective a
"A
-antagonist. Adrenaline had no effect on
HLsecretion in hepatocytes pretreatedwith chloroethylclonidine,
an irreversible a
"B
-selective antagonist. Inhibition of HL was not
induced by 10 lM methoxamine, a a
"A
-selective agonist. Thus,
adrenaline inhibited HL secretion through activation of the a
"
-
adrenoceptors subtype B, which have been shown to signal
through Ca#+ as well as cAMP. A similar reduction in HL
secretion was induced by the Ca#+-mobilizing hormones angio-
tensin II (100 nM) and vasopressin (12 nM), the Ca#+ ionophore
A23187 (2 lM), and by thapsigargin (1 lM), which inhibits the
INTRODUCTION
Hepatic lipase (HL) plays an important role in lipid metabolism.
HL hydrolyses phospholipid and triacylglycerol present in high-
and intermediate-density lipoproteins, and facilitates the selective
uptake of cholesterol from high-density lipoproteins and the
removal of remnant particles by the liver (for review see [1]). HL
may affect lipoprotein metabolism via its enzymic activity [2],
or by its ligand function towards lipoproteins [3–6]. By con-
tributing to reverse cholesterol transport and by lowering athero-
genic remnant particles in the circulation, HL is thought to
protect against the development of premature atherosclerosis. A
low HL has been shown to be a risk factor for premature
atherosclerosis [7,8]. In addition, HL activity inversely correlated
with progression of coronary atherosclerosis in patients on a
lipid-lowering diet [9]. In line with this, HL transgenic mice were
shown to accumulate less cholesterol in the aortic wall than non-
expressing littermates [10].
Catecholamines are responsible for the diurnal changes in HL
activity observed in rat liver, with HL being low when plasma
catecholamines are elevated [11]. In freshly isolated hepatocytes
adrenaline decreases HL secretion via activation of a
"
-adreno-
ceptors [11–13], which are generally thought to exert their action
via intracellular Ca#+. Recently, several subclasses of this receptor
Abbreviations used: HL, hepatic lipase ; 8-Br-cAMP, 8-bromo-cAMP; ER, endoplasmic reticulum; PAGE, polyacrylamide gel electrophoresis ; Endo
H, endo-b-N-acetylglucosaminidase H.
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ER Ca#+–ATPase pump. HL secretion was unaffected by ele-
vating cAMP with 10 lM forskolin or 1 lM 8-Br-cAMP. These
results suggest that the a
"B
-adrenergic effects on HL expression
are mainly mediated through elevation of intracellular Ca#+.
Chelation of extracellular Ca#+ and subsequent lowering of
intracellular Ca#+ with EGTA also inhibited HL secretion. In
pulse-chase experiments, adrenaline was shown to inhibit the
maturation of HL from the 53 kDa, Endo H-sensitive precursor
to the Endo H-resistant, catalytically active protein of 58 kDa. In
addition, adrenaline induced intracellular degradation of newly
synthesized HL. Similar post-translational effects, both quali-
tatively and quantitatively, were observed with A23187, thapsi-
gargin and EGTA. We conclude that the inhibition of HL
maturation and increase in intracellular degradation induced by
catecholamines, A23187, thapsigargin and EGTA is evoked by
changes in Ca#+ homoeostasis, possibly through lowering ER
Ca#+.
have been identified and shown to signal differentially [14–17].
The a
"A
-adrenergic receptor signals by stimulating Ca#+ influx
from the extracellular medium and mediates a tonic response
[18,19]. Thea
"
-subclassesB,Cand D induce a rapid IP
$
formation
and subsequent release of Ca#+ from intracellular stores [20,21].
In addition to calcium mobilization, the latter subclasses were
also shown to elevate cAMP [21,22]. Hepatocytes from different
species express different subclasses of a
"
-adrenergic receptors.
Rats, mice and hamsters mainly express a
"B
-adrenoceptors [23].
In isolated rat hepatocytes, the a
"B
-adrenoceptors were reported
to directly stimulate cAMP accumulation, rather than indirectly
in response to elevated Ca#+ [22]. The cAMP accumulation,
induced by the a
"
-receptors, depends on the maturity of the rats
from which the hepatocytes are isolated [24]. This may indicate
age-related changes in a
"
-adrenoceptor subclass expression. The
isolation procedure may also cause changes in expression of a
"B
-
adrenoceptors by rat liver cells [25]. Therefore, we decided to re-
investigate the signalling pathway involved in the adrenaline-
induced reduction of HL secretion in isolated hepatocytes.
In earlier studies, we showed that adrenaline acutely decreases
the maturation of HL and increases degradation of newly
synthesized HL protein [13]. To distinguish between the various
a
"
-adrenoceptors, we incubated hepatocytes with compounds
known to have different affinities for the a
"
-subtypes [26]. We
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show here that the a
"
-adrenoceptor subclass B mediates the
inhibitory effects of adrenaline on HL expression. Although a
"B
-
stimulation induces elevated Ca#+ and cAMP levels, the post-
translational effects of adrenaline on HL expression appear to be
only mediated by Ca#+. In order to study the mechanism of
action, the role of intracellular Ca#+ in the inhibition of HL
secretion by freshly isolated hepatocytes was studied.
EXPERIMENTAL
Materials
Adrenaline was obtained from Centrafarm BV (Etten-Leur, The
Netherlands) and prazosin from Pfizer (Brussels, Belgium).
Propranolol, thapsigargin, angiotensin II, vasopressin, 8-bromo-
cAMP and EGTA were purchased from Sigma (St. Louis,
MO, U.S.A.). Methoxamine, WB4101 and chloroethylclonidine
were from Research Biochemicals International (Natick, MA,
U.S.A). A23187 was from Boehringer–Mannheim (Mannheim,
Germany). Benzamidine and amino acids were purchased from
Merck (Darmstadt, Germany). Trasylol was from Bayer BV
(Mijdrecht, The Netherlands) and heparin from Leo Pharm-
aceutical Products BV (Weesp, The Netherlands). Protein A-
Sepharose and CNBr-activated Sepharose 4B were obtained
from Pharmacia (Uppsala, Sweden). Ham’s F10 and methionine-
free MEM were from Gibco–BRL (Paisley, U.K.). Glycerol
tri[9,10(n)-$H]oleate (5–20 Ci}mmol) was purchased from
Amersham (Amersham, U.K.), Tran-$&S-label (1100 Ci}mmol)
was from ICN (Costa Mesa, CA, U.S.A.). Broad range markers
for SDS}PAGE came from Bio-Rad (Richmond, CA, U.S.A.).
All other chemicals were from Sigma.
Hepatocyte isolation and incubation
Hepatocytes were isolated from male Wistar rats (200–300 g) by
in situ perfusion with collagenase type I, whereafter non-paren-
chymal cells were removed by differential centrifugation ac-
cording to Seglen [27]. The cells were washed with Ham’s F10
medium containing 25 U}ml of heparin to remove residual
extracellularly bound HL. Then the cells were resuspended at
3–5¬10' cells}ml in Ham’s F10 medium containing 25 U}ml of
heparin and 20% heat-inactivated, dialysed bovine serum [28].
The cell suspensions were incubated at 37 °C under an at-
mosphere of 95% O
#
}5% CO
#
in a shaking water bath. Cell
viability ranged from 85 to 95%, as determined by Trypan Blue
exclusion and remained essentially unaltered during all incu-
bations. At the indicated times, 0±5 ml samples were collected
from the incubations and put on ice. Cells and media were
separated by centrifugation (5 s, 10000 g, 4 °C) and the cell-free
media were used for analysis of secreted HL.
HL activity and protein
HL activity was determined by a triacylglycerol hydrolase assay
at pH 8±5 in 0±6 M NaCl using a gum acacia-stabilized glycerol
[$H]trioleate emulsion as substrate [28]. Assays were performed
for 45 min at 30 °C. Enzyme activities are expressed as mU (nmol
of free fatty acids released per min). The lipase activity in the cell-
free media was completely inhibited by goat anti-HL IgGs [29].
The amount of HL protein in cell-free media was measured by
a solid-phase ELISA as described previously [29], with minor
modifications. HL was sandwiched between goat polyclonal and
rabbit polyclonal anti-HL IgGs. Absorbances were read against
a standard curve prepared by serial dilutions of partly purified
rat HL. The latter was prepared from post-heparin rat liver
perfusates by affinity chromatography on Sepharose-heparin.
HL activity was eluted with a linear 0±2–1±0 M NaCl gradient in
1% BSA; peak fractions were pooled and kept at ®80 °C until
use.
Pulse-chase experiments with [35S]methionine
Pulse-chase experiments were performed as described before [13].
In short, freshly isolated hepatocytes were pre-incubated for
30 min in methionine-free MEM containing 25 U}ml of heparin
and 20% heat-inactivated, dialysed bovine serum. After a 5 min
pulse with 80 lCi}ml of Tran-$&S-label, cold methionine was
added at a final concentration of 1 mM. After washing twice by
centrifugation (2 min, 50 g, room temperature) and resuspending
in Ham’s F10, the cells were incubated further in Ham’s F10
medium containing 25 U}ml of heparin, 20% serum and 1 mM
cold methionine. After the indicated chase times the incubations
were stopped on ice. The whole cell suspension was lysed with
1% Triton X-100, 0±1% sodium deoxycholate, 25 U}ml heparin,
1 mM methionine and the protease inhibitors leupeptin (1 lg}
ml), antipain (1 lg}ml), chymostatin (1 lg}ml), pepstatin
(1 lg}ml), benzamidine (1 mM), Trasylol (10 IU}ml) and EDTA
(1 mM). After a 30 min incubation on ice, the lysates were
centrifuged for 10 min at 10000 g at 4 °C, and the supernatants
were collected. These post-nuclear supernatants were used for
immunoprecipitation.
Immunoprecipitations
HL protein was immunoprecipitated by goat polyclonal anti-HL
IgGs immobilized onto Sepharose [29]. Twenty mg of the goat
antibody preparation was coupled per 1 g of CNBr-activated
Sepharose 4B according to the manufacturer’s instructions. The
post-nuclear supernatants (1 ml) were incubated overnight at
4 °C with 50 ll of a 50% slurry of the immobilized anti-HL
IgGs. The beads were collected by centrifugation, and then
washed twice with 1 ml of successively PBS, 1 M NaCl in PBS,
0±2% Tween-20 in PBS, and finally PBS (all at 4 °C). The bound
proteins were released by a 5 min incubation at 95 °C in Laemmli
sample buffer without b-mercaptoethanol. After removal of the
beads the proteins were reduced with b-mercaptoethanol and
then resolved by SDS}PAGE on 10%-gels. Protein bands were
visualized by staining with Coomassie Brilliant Blue, and their
molecular masses were estimated using broad range markers run
in parallel. To visualize and quantify the radioactivity in the
bands, the dried gels were analysed by phosphor imaging using
CS screens and the GS363 Molecular Imager (Bio-Rad, Rich-
mond, CA, U.S.A.).
Transferrin was immunoprecipitated from the cell free media
as outlined above, using 10 ll of a 1:10 diluted antiserum against
rat transferrin (a kind gift from Dr H. G. van Eijk, Rotterdam,
The Netherlands) followed by 20 ll of a 50% slurry of protein
A-Sepharose [13].
Statistics
Statistical significances were determined by one-way analysis of
variance (one-way ANOVA), followed by the Student–
Newman–Keuls test [30].
RESULTS
Characterization of the a1-adrenoceptor subtype involved in HL
secretion
In the presence of heparin, freshly isolated hepatocytes secreted
1±34³0±19 mU}10' cells of HL activity (mean³S.D.; n¯ 3)
into the medium in 1 h. When adrenaline (10 lM) was present
from the start of the incubation, the secretion of HL activity and
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Table 1 Secretion of HL activity in the presence of different a1-adrenergic
(ant)agonists
Freshly isolated hepatocytes were incubated with 1 lM propranolol in control medium and in
medium containing the indicated compounds. Part of the hepatocytes were preincubated with
chloroethylclonidine for 20 min and then adrenaline was added. After 60 min, samples of the
cell-free media were assayed for HL activity and mass. Data are expressed as percentage of
control (1±34³0±19 mU/106 cells and 20±4³4±9 mU/lg respectively) and represent
mean³S.D. (n ¯ 3). Statistically significant differences from control are indicated by the
asterisks (P ! 0±05).
HL activity HL mass HL specific activity
(%) (%) (%)
Control 100 100 100
Adrenaline (10 lM) 57³6* 48³6* 119³15
Adrenaline (10 lM)­prazosin (1 lM) 98³6 91³24 108³31
Adrenaline (10 lM)­WB4101 (10 lM) 67³7* 51³13* 131³30
Adrenaline (10 lM)
­chloroethylclonidine (100 lM)
97³11 103³10 94³14
Methoxamine (10 lM) 91³12 96³18 95³11
Figure 1 Secretion of HL activity in the presence of different concentrations
of a1-adrenergic antagonists
Freshly isolated hepatocytes were incubated with 1 lM propranolol in control medium (C) and
in medium containing 10 lM adrenaline either alone or in combination with different
concentrations of WB4101 (U) or prazosin (E). After 60 min of incubation the cell-free media
were assayed for HL activity.
HL mass decreased to approx. 60% of control (Table 1).
Propranolol (1 lM), which was included in these experiments to
exclude possible interference by the b-adrenergic pathway, did
not alter the secretion of HL activity and mass in control, nor in
adrenaline-treated hepatocytes [13]. On the other hand, the
response to adrenaline was abolished by co-incubation with
1 lM prazosin, confirming the involvement of the a
"
-adrenergic
receptor pathway.
To distinguish between the various a
"
-adrenoceptor subtypes,
we incubated freshly isolated hepatocytes with adrenaline and
propranolol in combination with antagonists that have different
Table 2 Secretion of HL activity is inhibited by increasing intracellular
Ca2+ but not cAMP levels
Hepatocytes were incubated for 60 min in the presence of the compounds indicated, whereafter
the cell-free media were assayed for HL activity and mass. Data are expressed as percentage
of control (1±47³0±62 mU/106 cells and 20±4³4±9 mU/lg respectively) and represent
mean³S.D. for 3–5 independent experiments. Asterisks indicate statistically significant
differences from control (P ! 0±05).
HL activity HL mass HL specific activity
(%) (%) (%)
Control 100 100 100
Adrenaline (10 lM)­propranolol (1 lM) 57³6* 48³6* 119³15
A23187 (2 lM) 67³17* 56³5* 120³19
Thapsigargin (1 lM) 57³10* 56³2* 102³27
Angiotensin II (100 nM) 72³15* 63³4* 114³28
Vasopressin (12 nM) 70³10* 59³3* 119³20
Forskolin (10 lM) 96³6 77³19 125³32
8-Br-cAMP (1 lM) 92³18 74³6 124³22
affinities for the a
"
-adrenoceptor subtypes [26]. In the presence of
1 lM WB4101, an a
"A
-antagonist, the effect of adrenaline on
secretion of HL activity and HL mass was hardly affected (Table
1). Adrenaline was less effective when higher concentrations (up
to 100 lM) of WB4101 were added (Figure 1). Adrenaline was
inactive in the presence of only 0±1 lM prazosin, demonstrating
that prazosin was at least 1000-fold more potent than WB4101.
Adrenaline had no effect on HL secretion when hepatocytes were
pre-incubated with 100 lM chloroethylclonidine, an irreversible
a
"B
-selective antagonist (Table 1). Moreover, the effect of adrena-
line on secretion of HL activity and HL mass was not mimicked
by 10 lM methoxamine, an a
"A
-selective agonist. Under all
conditions tested, the specific enzyme activity of secreted HL was
not significantly changed (Table 1). These findings indicate that
adrenaline inhibited HL secretion by hepatocytes through ac-
tivation of the a
"
-adrenoceptors subtype B.
The effect of adrenaline is mediated by changes in intracellular
calcium
In hepatocytes of adult rats a
"B
-adrenoceptors are shown to
signal simultaneously through Ca#+ mobilization and cAMP
accumulation [22]. We therefore studied through which signal
adrenaline induces inhibition of HL secretion. When hepatocytes
were incubated with the Ca#+ ionophore A23187 (2 lM), the HL
activity and HL mass secreted into the cell-free medium was
reduced to levels comparable to that with adrenaline (Table 2).
Thapsigargin (1 lM), which elevates intracellular Ca#+ by mobil-
izing Ca#+ stores from the ER [31], also induced a 40% fall in HL
activity and HL mass in the medium. In addition, the Ca#+-
mobilizing hormones angiotensin II (100 nM) and vasopressin
(12 nM) reduced secretion of HL similar to adrenaline. On the
other hand, secretion of HL activity and HL mass was not
affected by incubation with 10 lM forskolin or 1 lM 8-Br-
cAMP. Under all conditions tested, the specific enzyme activity
of the secreted HL was not significantly affected (Table 2). These
results imply that the a
"B
-adrenergic effect of adrenaline on HL
secretion is mainly mediated by the Ca#+ signal.
Opposite changes in intracellular Ca2+ levels inhibit the secretion
of HL
As shown above, elevation of intracellular Ca#+ by A23187,
thapsigargin, angiotensin II or vasopressin results in a similar
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Figure 2 Effect of chelating extracellular Ca2+ on secretion of HL activity
Freshly isolated hepatocytes were incubated in Ham’s F10 medium containing 0±3 mM Ca2+
and different concentrations of EGTA. After 60 min the cell-free media were assayed for HL
activity. Data are expressed as percentage of control (1±54³0±80 mU/106 cells) and represent
mean³S.D. for 2–6 independent experiments. The numbers indicate the free extracellular Ca2+
concentrations (nM) calculated for these conditions [33,34].
inhibition of HL secretion as with adrenaline. Chelation of
extracellular Ca#+ with EGTA has also been shown to inhibit
secretion of HL activity [32]. To establish at which concentration
of extracellular free Ca#+ HL secretion is affected, freshly isolated
hepatocytes were incubated for 1 h in medium containing 0±3 mM
Ca#+ and different concentrations of EGTA. Secretion of HL
activity (Figure 2) and HL protein (not shown) was unaffected by
EGTA up to 0±4 mM. Between 0±4 and 0±5 mM EGTA, secretion
of HL abruptly fell by 40%. A further increase in EGTA
concentration (up to 1 mM) had no additional inhibitory effect.
Calculation of free Ca#+ concentrations [33,34] in the media show
that the threshold value was between 300 and 160 nM free
extracellular Ca#+. Half-maximal reduction in HL secretion was
observed at approximally 200 nM free Ca#+, which is close to
intracellular Ca#+ concentrations reported for rat hepatocytes
[22,35–37]. Apparently, the inhibitory effect of EGTA on HL
secretion occurs when the free extracellular Ca#+ concentration
falls to levels close to or below intracellular Ca#+.
Effects of adrenaline, thapsigargin and EGTA on HL maturation
The inhibitory effect of the Ca#+-mobilizing hormones, as well as
of A23187, thapsigargin and EGTA are evident within the first
hour of incubation. During this period, mainly presynthesized
HL is secreted [13,29]. Thus, the acute effects on HL secretion are
mainly post-translational. In pulse-chase experiments with [$&S]-
methionine, the mechanism by which adrenaline, thapsigargin,
A23187 and EGTA lower HL secretion by rat hepatocytes was
compared. To study post-translational processing of HL, hepato-
cytes were pulsed with [$&S]methionine for 5 min in control
medium. During the chase, equal parts of the cell suspension
were incubated without any addition, or with either adrenaline,
A23817, thapsigargin or EGTA.
After a 5 min pulse, HL was immunoprecipitated as 53 kDa,
Endo H-sensitive protein [13,38]. During the chase in control
suspensions, the 53 kDa protein gradually decreased (Figures 3A
and 3B). In parallel the mature, Endo H-resistant HL protein of
58 kDa was formed. Total [$&S]HL, which was determined by the
sum of the radioactivity in the 53 and 58 kDa protein, was not
altered during the 45 min of chase, indicating that there was no
degradation of HL under these conditions. When adrenaline
(10 lM) was present during the chase, the intracellular 53 kDa
protein disappeared at a rate similar to control (Figures 3A and
3B; Adr). However, the appearance of the mature 58 kDa protein
was retarded compared with control cells. After 45 min of in-
cubation, total [$&S]HL was 30% less than in control incubations.
The loss in total [$&S]HL during incubation with adrenaline was
not recovered in any immunoreactive protein, and may reflect
complete degradation. Overall, the results indicate that adrena-
line inhibited the maturation of HL protein and increased the
degradation of HL.
When hepatocytes were chased in the presence of 1 lM
thapsigargin, the $&S-labelled 53 kDa protein disappeared at a
similar rate to that in control or adrenaline-treated cells (Figures
3A and 3B; TSG). The formation of the 58 kDa protein was
retarded compared with control cells to an extent similar to
adrenaline-treated cells. At the end of the chase with thapsigargin,
total [$&S]HL was decreased to about 70% of control. With 2 lM
A23187 (not shown) or with 0±5 mM EGTA (Figures 3A and 3B)
the effects on the disappearance of the 53 kDa protein, the
appearance of the 58 kDa protein, and loss of total [$&S]HL were
superimposable to those observed with thapsigargin and ad-
renaline. In contrast to secretion of [$&S]HL, the secretion of
[$&S]transferrin was unaffected after up to 45 min of incubation
with either adrenaline, thapsigargin or EGTA (Figure 3C).
DISCUSSION
In freshly isolated hepatocytes secretion of HL was shown to be
inhibited by adrenaline through activation of the a
"
-adrenoceptor
pathway [11–13]. Rat liver was reported to be enriched in the a
"B
-
subtype [23,39]. In our isolated rat hepatocytes WB4101, an a
"A
-
antagonist, was at least 1000-fold less potent than prazosin in
preventing the effect of adrenaline on HL secretion. When pre-
incubated with chloroethylclonidine, an a
"B
-antagonist, the
adrenaline-induced inhibition of HL secretion was completely
abolished. The effect of adrenaline was mimicked by phenyl-
ephrine [13], but not by the selective a
"A
-agonist methoxamine.
Thus, adrenaline inhibited the secretion of HL via activation of
the a
"B
-adrenergic receptors. This adrenoceptor subtype was
recently described to signal simultaneously through elevation of
intracellular Ca#+ and cAMP [22]. Several observations suggest
that the effect of adrenaline is mediated via Ca#+ rather than
cAMP. First, similar inhibition of HL secretion was observed
with the Ca#+-mobilizing hormones vasopressin and angiotensin
II. In addition, the Ca#+ ionophore A23187 and thapsigargin had
similar effects on the secretion of HL. Second, the effect of
adrenaline could not be mimicked by elevating cAMP with
forskolin or 8-Br-cAMP. cAMP may be important for poten-
tiating the IP
$
-induced Ca#+ release from the ER [40,41]. How-
ever, co-incubation of hepatocytes with forskolin and adrenaline
showed that the forskolin-mediated elevation of cAMP did not
modulate the inhibitory effect of adrenaline on HL secretion (not
shown).
The acute effects of the Ca#+-mobilizing hormones, A23187,
thapsigargin and EGTA on HL secretion are mainly post-
translational. They are evident within the first hour, during
which mainly pre-synthesized HL is secreted [13,29]. Pulse-chase
experiments with [$&S]methionine showed that adrenaline, A231-
87, thapsigargin, as well as EGTA retard the maturation of the
53 kDa, high mannose precursor to the mature 58 kDa HL
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Figure 3 Maturation of HL in the presence of adrenaline, thapsigargin or EGTA
Hepatocytes were pulsed with [35S]methionine for 5 min in the absence of any agent. After washing the cells in fresh medium, part of the cell suspension was incubated in control medium, and
another part was incubated in medium containing either 10 lM adrenaline (Adr), 1 lM thapsigargin (TSG) or 500 lM EGTA. At the times indicated samples were collected and HL was
immunoprecipitated from the whole cell suspensions. The [35S]HL was analysed by SDS/PAGE followed by phosphor imaging. (A) A representative image for a chase in the absence (®) and
presence (­) of Ca2+-modulating agents. The apparent molecular weight of the bands is indicated in kDa. The quantified data in (B) are expressed as percentage of total radioactivity in the
HL bands at the start of the chase (mean³S.D. n ¯ 3). They show, from left to right, the disappearance of the 53 kDa protein, appearance of the 58 kDa protein, and total radioactivity in
the 53 plus 58 kDa bands in the absence (D) or presence of either adrenaline (Adr, E), thapsigargin (TSG, +), or EGTA (U). (C) Shows a fluorograph of [35S]transferrin, which was
immunoprecipitated from the extracellular medium after 45 min of chase in the absence (®) or presence (­) of either adrenaline (Adr), thapsigargin (TSG) or EGTA.
protein, and stimulate the intracellular degradation of HL. Thus,
the mechanisms by which HL secretion was inhibited by these
agents were highly similar.
Maturation and secretion of HL was inhibited when the
intracellular Ca#+ concentration was increased by incubation
with Ca#+-mobilizing hormones, A23187 and thapsigargin, sug-
gesting that the intracellular Ca#+ concentration itself may
influence the processing of HL. However, HL maturation was
inhibited similarly when the free extracellular Ca#+ was reduced
with EGTA to concentrations close to or below intracellular
Ca#+. Under these conditions, intracellular Ca#+ may be reduced,
and EGTA may inhibit HL processing by lowering intracellular
Ca#+. These results imply that, besides elevation of intra-
cellular Ca#+, also the lowering of intracellular Ca#+ mimics the
effect of adrenaline on maturation and secretion of HL. EGTA
may induce a different process than the Ca#+-mobilizing agents,
which leads to a similar inhibition of HL maturation and increase
in HL degradation. Alternatively, this apparent contradiction
may be resolved by considering the effects on Ca#+ levels in the
ER. The a
"B
-adrenoceptor stimulates the release of Ca#+ from
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IP
$
-sensitive stores, such as the ER [20–22]. The Ca#+ ionophore
A23187 will carry Ca#+ across the ER membrane along the
gradient of Ca#+, thereby lowering ER Ca#+ [42,43]. Thapsigargin
increases intracellular Ca#+ by inhibition of the Ca#+–ATPase in
the ER membrane; Ca#+ is no longer retrieved from the cytosol
and the Ca#+ level in the ER decreases [31,43]. Incubation of
hepatocytes with EGTA depletes non-mitochondrial Ca#+ pools,
including the ER [43]. Therefore, the decreased Ca#+ level in the
ER, induced by incubation of hepatocytes with adrenaline,
A23187, thapsigargin and EGTA, may evoke the effects on HL
processing.
In which order the retardation of HL maturation and degra-
dation of HL protein occurs is unclear. Lowering ER Ca#+ may
increase the degradation process by increasing the activity of
Ca#+-sensitive proteases in the ER. Maturation of a
"
-antitrypsin
and the asialoglycoprotein receptor was also reported to be
decreased by lowering Ca#+ in the ER [44,45]. In contrast,
secretion and maturation of the glycoprotein transferrin was not
affected by adrenaline, thapsigargin or EGTA. Depletion of ER
Ca#+ was also shown to selectively increase the degradation
transfected T-cell antigen receptor-b and CD3-d, but not of
CD3-c and CD3-e-b dimers in CHO cells [46]. Alternatively, the
effects on HL processing may be mediated by processes other
than the Ca#+-dependent stimulation of proteases in the ER. A
low Ca#+ level in the ER may change the affinity of HL for
possible chaperones, whereafter HL may become more sus-
ceptible to ER degradation. Several chaperones resident in the
ER are reported to be calcium-dependent [47]. The existence of
a chaperone with selectivity towards HL and other lipases was
implicated from mice suffering from combined lipase deficiency
[48,49]. Thus, a specific Ca#+-sensitive chaperone may be involved
in HL maturation. We conclude that the inhibition of HL
maturation and increase in intracellular degradation by catecho-
lamines, A23187, thapsigargin and EGTA are mediated by
changes in Ca#+ homoeostasis, possibly through lowering ER
Ca#+.
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